Credits

Handouts

Faculty

John Dean, MA, CCC-SLP Related seminars and products

---

JOHN DEAN, MA, CCC-SLP, is a speech-language pathologist specializing in the treatment of Parkinson’s disease and related disorders. In 2009, he developed the first transdisciplinary Parkinson’s program for Life Care Centers of America – a program became the flagship for a network of 15 transdisciplinary teams throughout Colorado and Wyoming as well as the second network throughout Tennessee, Georgia, South Carolina, and Northern Florida. Since 2013, Mr. Dean has served as a member of the faculty for the Allied Team Training Program (ATTP) from the National Parkinson Foundation and International Parkinson’s and Movement Disorder Society. He also serves in the leadership of the Health Professionals Special Interest Group of the International Parkinson’s and Movement Disorder Society (MDS) and is a member of the MDS Task Force on Technology as well as the Speech Study Group. Mr. Dean has certifications in LSVT ®LOUD, Parkinson’s Voice Project (SPEAK OUT®), and Parkinson’s Wellness Recovery! (He developed the breath, voice, and some of the cognitive components of that program). In addition, he has received further instruction and/or certification in Dance for PD, Neurologic Music Therapy, and developed Parkinson-specific material based on Pilates principles.

 

Full Disclosure:

Financial - Receives a speaking honorarium from Vyne Education, Parkinson’s Wellness Recovery (PWR!), International Parkinson and Movement Disorder Society.

Additional Info

Program Information

Target Audience

Outline

Course Outline

REVIEW OF PARKINSON’S DISEASE AND RELATED DISORDERS

• History of Parkinson’s
  • Atypical diagnoses
  • Drug-induced, vascular, metabolic, and other causes of PD

PARKINSON’S MEDICATIONS

• Basic methods of action for primary PD medication
  • Dosages and side effects
• Common ancillary medications for:
  • Psychological symptoms
  • Orthostatic hypotension
  • Incontinence
  • Daytime fatigue/sleepiness
  • Cognitive changes

• Timing of PT/OT/ST interventions in conjunction with meds

{CASE STUDY} RECENTLY DIAGNOSED MALE WITH YOUNG ONSET PD

ADVANCED THERAPIES FOR PARKINSON’S

• Deep brain stimulator surgery (side effects and issues)
• Enteral suspension of carbidopa/levodopa
• Ablative surgeries
• On the horizon – subcutaneous continuous release of apomorphine and carbidopa/levodopa, A2A receptor antagonists and other targets

{CASE STUDY} FEMALE WITH MID-STAGE PD, S/P DBS SURGERY

OVERVIEW AND HISTORY OF REHAB TEAM APPROACHES TO TREATMENT

• Center of Excellence Model
  • Core features and components
• Interdisciplinary and transdisciplinary team models around the world

KEY ASPECTS OF PARKINSON’S TEAM DEVELOPMENT

• Key training and competencies
• Roles of key members including discipline-specific competencies
  • Gait and balance deficits
  • Functional transfers
  • ADLs
  • Communication and swallowing deficiencies

ASSESSMENTS AND DOCUMENTATION

• Intake and evaluation
• Key metrics of clinical progress including minimum detectable-change

SPECIAL TOPICS

• Dual task treatment for PD with PT/OT/ST team
  • Key concepts with research underpinning
  • Techniques for team approaches
    • Sequencing activities
    • Safety awareness
    • Memory deficits
• Marketing a team-based Parkinson’s program
  • Including sample presentations for consumer populations as well as medical presentations
  • Sample press release
• Differential diagnosis of atypical Parkinson’s disorders
  • Specific clinical features
    • Progressive supranuclear palsy
    • Corticobasal ganglionic degeneration
    • Multiple system atrophy

{CASE STUDY} FEMALE W/ 4-YEAR HISTORY OF UNSPECIFIED PARKINSONISMS 

Objectives

1. Discuss core motor and nonmotor features of PD as well as relevant Parkinsonisms
2. Identify causes of different types of Parkinsonisms including drug induced, metabolic, and vascular, as well as the atypical diagnoses such as PSP, CBD, MSA, and relevant subtypes
3. Restate primary medication treatments for Parkinson’s disease including treatments for comorbidities such as cognitive changes, psychological issues, autonomic features, and related problems
4. Outline the key components of the Parkinson’s rehab team and highlight key roles of each member
5. List core features of Parkinson’s that needs to be evaluated and relevant treatment approaches for each
6. Review key components of dual task interventions for Parkinson’s, including the relevant potential roles for each team member

Reviews